Abstract
The prevalence of primary headache (PH) in a multiple sclerosis (MS) sample vs. control healthy subjects was investigated at a neurological clinic in 2004–2005: 122 of 238 (51%) MS patients and 57 of 238 (23%) controls proved to be affected by headache. The groups did not differ for the rates of PH types. Headache types of MS patients were comparable to those of PH patients that were observed at the same institute in a case-control comparison. First symptoms of headache preceded those of MS in two thirds of cases. Headache features did not significantly change after MS onset. Comorbidity of MS and PH could be explained by some common clinical and biological traits.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Watkins SM, Espir M (1969) Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatry 32:35–37
Rolak LA, Brown S (1990) Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol 237:300–302
D’Amico D, La Mantia L, Rigamonti A et al (2004) Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 24:980–984
Freedman MS, Gray TA (1989) Vascular headache: a presenting symptom of multiple sclerosis. Can J Neurol Sci 16:63–66
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24[Suppl 1]:9–160
Haas DC, Kent PF, Friedman DI (1993) Headache caused by a single lesion of multiple sclerosis in the periacqueductal gray area. Headache 33:452–455
Gee JR, Chang J, Dublin AB, Vijayan N (2005) The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 45:670–677
Pölmann W, Erasmus LP, Feneberg W et al (2002) Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 59:636–639
Stewart WF, Lipton RB, Liberman J (1996) Variation in migraine prevalence by race. Neurology 47:52–59
Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139
Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutation in the Ca2+ channel gene CACNL1A4. Cell 87:543–552
De Fusco M, Marconi R, Silvestri L et al (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196
Wulff H, Calabresi PA, Allie R et al (2003) The voltage gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest 111:1703–1713
Waxman SG (2001) Acquired channelopathies in nerve injury and MS. Neurology 56:1621–1627
Munno I, Marinaro M, Bassi A et al (2001) Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 41:764–767
Beebe AM, Cua DJ, de Waal Malefyt R (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13:403–412
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vacca, G., Marano, E., Brescia Morra, V. et al. Multiple sclerosis and headache co-morbidity. A case-control study. Neurol Sci 28, 133–135 (2007). https://doi.org/10.1007/s10072-007-0805-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-007-0805-1